This is an AI-Generated podcast. This podcast discusses the FDA’s recent guidance on inclusion and diversity in clinical trials and features an interview with Mumbi Kairu, a nurse practitioner at the Pamoja Research Institute. Kairu discusses the crucial need for diversity in clinical trials, noting that while the FDA guidance is a step in the right direction, it does not adequately address the cultural and socioeconomic barriers that prevent diverse participation. Kairu argues that building community trust should be paramount, as historical events like the Tuskegee experiment still generate mistrust. She suggests involving more community physicians and clinics could help … Continue reading FDA’s Diversity in Clinical Trials Plan: Why It Fails to Address Key Barriers for Underrepresented Communities